Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 23.
doi: 10.2215/CJN.0000000953. Online ahead of print.

Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN

Giliane Nanchen  1   2 , Maddalena Marasà  1 , Matteo Breno  1 , Carolina Martinatto  1 , Miriam Rigoldi  1 , Marina Noris  1 , Elena Bresin  1 , Sara Gamba  1 , Laura Bottanelli  1 , Zahra Imanifard  1 , Rossella Piras  1 , Roberta Donadelli  1 , Matias Trillini  1 , Francesco Emma  3 , Marina Vivarelli  4 , Luca Antonucci  3   5 , Camillo Carrara  1   6 , Piero Ruggenenti  1   6 , Gaetano La Manna  7   8 , Giorgia Comai  7   8 , Enrico Vidal  9 , Valeria Silecchia  9 , Andrea Pasini  10 , Andrea Ranghino  11 , Alessandra Cingolani  11 , Gabriele Donati  12   13 , Silvia Giovanella  13 , Luigi Biancone  14 , Laura Valenza  14 , Enrico Verrina  15 , Andrea Angeletti  15 , Giuliano Brunori  16 , Laura Sottini  16 , Mario Giordano  17 , Diletta Domenica Torres  17 , Federico Alberici  18 , Federica Mescia  18 , Umberto Maggiore  19 , Micaela Gentile  19 , Ariela Benigni  1 , Giuseppe Remuzzi  1 , Erica Daina  1 ; Italian Registry of MPGN
Collaborators, Affiliations

Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN

Giliane Nanchen et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: ESKD; GN; MPGN (membranoproliferative GN); complement; epidemiology and outcomes; glomerular disease; glomerulopathy; longitudinal data analysis; proteinuria.

PubMed Disclaimer

References

    1. Cook HT, Pickering MC. Histopathology of MPGN and C3 glomerulopathies. Nat Rev Nephrol. 2015;11(1):14–22. doi: 10.1038/nrneph.2014.217 - DOI
    1. Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010;25(8):1409–1418. doi: 10.1007/s00467-009-1322-7 - DOI
    1. Donadelli R, Pulieri P, Piras R, et al. Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN. Front Immunol. 2018;9:2329. doi: 10.3389/fimmu.2018.02329 - DOI
    1. Iatropoulos P, Noris M, Mele C, et al. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. Mol Immunol. 2016;71:131–142. doi: 10.1016/j.molimm.2016.01.010 - DOI
    1. Servais A, Noël LH, Roumenina LT, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 2012;82(4):454–464. doi: 10.1038/ki.2012.63 - DOI

LinkOut - more resources